New York researchers developing estrogen-based biomaterial to treat spinal cord injuries

Written by Alan Condon | October 23, 2019 | Print  |

Researchers at Troy, N.Y.-based Rensselaer Polytechnic Institute designed a biomaterial that could provide targeted treatment to injured spinal cords and tissue to prevent additional damage, reports Sci Tech Daily.

Four insights:

1. Researchers polymerized estrogen into a slow-releasing biomaterial to protect nervous system cells and promote regeneration.

2. The polymer targeted injured tissue and emitted estrogen as a therapeutic over a period of years when implanted on the spinal cord.

3. The researchers used a photo-triggered chemical process to synthesize the estrogen into polymer chains that were spun into fibers for spinal cord implantation.

4. Researchers are eyeing preclinical testing, where they can explore how their polymerized fibers would work in a living system.

More articles on biologics:
7 big moves for Hospital for Special Surgery in 2019
5 highest paying physician specialties — Neurosurgeon No. 1 at $401k
Dr. Thomas Loftus: How a single-payer system would harm spine practice in the US

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers